iShares Morningstar Mid-Cap Value (JKI) Rises 0.4% for Sep 17

September 17, 2017 - By Dolores Ford

Sep 17 is a positive day so far for iShares Morningstar Mid-Cap Value (NASDAQ:JKI) as the ETF is active during the day after gaining 0.4% to hit $149.5 per share. The exchange traded fund has 388.70M net assets and 0.98% volatility this month.

Over the course of the day 3,425 shares traded hands, as compared to an average volume of 9,480 over the last 30 days for iShares Morningstar Mid-Cap Value (NASDAQ:JKI).

The ETF is -0.48% of its 52-Week High and 32.28% of its low, and is currently having ATR of 1.51. This year’s performance is 15.01% while this quarter’s performance is 2.77%.

The ETF’s YTD performance is 0%, the 1 year is 0% and the 3 year is 0%.

More important recent iShares Morningstar Mid Value Idx (ETF) (NASDAQ:JKI) news were published by: which released: “The Best ETF For Mid-Cap Exposure” on April 10, 2017, also published article titled: “5 Millennial Friendly ETF Investing Ideas”, published: “The 50 Best Mutual Funds and ETFs, Period” on January 24, 2017. More interesting news about iShares Morningstar Mid Value Idx (ETF) (NASDAQ:JKI) was released by: and their article: “Best ETFs For Investors 2017” with publication date: August 23, 2016.

iShares Morningstar Mid Cap Value ETF, formerly iShares Morningstar Mid Value Index Fund , is an exchange-traded fund. The ETF has market cap of $388.70 million. The Fund seeks investment results that correspond generally to the price and yield performance of the Morningstar Mid Value Index (the Value Index). It has a 15.74 P/E ratio. The Value Index measures the performance of stocks issued by mid-capitalization companies that have exhibited above-average value characteristics as determined by Morningstar’s index methodology.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: